Skip to content

DOCTEUR ABBOUD

Active
Private limited companyfounded 2002active for 23 yearsPenelopelaan 23, 1190 Vorst, BelgiumKBO/BCE: BE 0479.007.180
Summary

DOCTEUR ABBOUD has been active since 2002 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €117,668 and a net result of -€50,905. Equity has been shrinking by about 6.7% per year since 2019. Its solvency ranks better than 27% of 3,033 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).

Overview

Official details

Source: KBO
Status
Active since 13-12-2002 Normal situation
Activity
Specialist medical practice NACE 86220and 1 other
Joint committee
336 Paritair Comité voor de vrije beroepen · annual accounts 30-06-2024
Establishment units
2.232.958.905 1190 Vorst, since 11-12-2002
2.232.959.103 1000 Brussel, since 01-01-2010
Financial year end
31 December
Peppol
Reachable since 18-02-2026

Board and ownership

Board

Financial position

89 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
0.1%
Annual accounts 2025
Gross margin
€106,346
Turnover
≈ €200,000
estimated
Loss
€50,905
Equity
€117,668
Total assets
€395,107
  • 2025 accounts filed 23 days after the deadline
Score breakdownraises riskLoss of €50,905 (financial year 2025)lowers riskSector: Human health activities (NACE 86)Size: total assets €395,107Figures for financial year 2025 (filed on 26-08-2026)Show the evidence

Checked score

Score 2025
89 / 100
Excellent
Probability in this band: under 0.55%
Financially stronger than 17% of micro companies in human health (NACE 86)
Financial strength · tick: 2024
Average
Solvency 55+7
equity 29.8% of total assets
Liquidity 50-13
short-term debt 40.6% · cash 15.1%
Profitability 53-45
return on assets -12.9%
Bankruptcy probability within 12 months
0.1% Very low
0%0.5%1.5%4%10%≥ 25%

About 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,168 companies, NACE 86, micro)
Last 24 months 12-2024: 0.3% 01-2025: 0.5%▲ +0.2 percentage points vs 12-2024 02-2025: 0.5%● unchanged vs 01-2025highest value 03-2025: < 0.1%▼ -0.5 percentage points vs 02-2025lowest value 04-2025: < 0.1%● unchanged vs 03-2025lowest value 05-2025: < 0.1%● unchanged vs 04-2025lowest value 06-2025: < 0.1%● unchanged vs 05-2025lowest value 07-2025: < 0.1%● unchanged vs 06-2025lowest value 08-2025: < 0.1%● unchanged vs 07-2025 09-2025: < 0.1%● unchanged vs 08-2025 10-2025: < 0.1%● unchanged vs 09-2025 11-2025: < 0.1%● unchanged vs 10-2025 12-2025: < 0.1%● unchanged vs 11-2025 01-2026: < 0.1%● unchanged vs 12-2025 02-2026: 0.1%▲ +0.1 percentage points vs 01-2026 03-2026: 0.1%● unchanged vs 02-2026 04-2026: 0.1%● unchanged vs 03-2026 05-2026: 0.1%● unchanged vs 04-2026 06-2026: 0.2%▲ +0.1 percentage points vs 05-2026 07-2026: 0.4%▲ +0.2 percentage points vs 06-2026 08-2026: 0.4%● unchanged vs 07-2026 09-2026: 0.1%▼ -0.3 percentage points vs 08-2026 10-2026: 0.1%● unchanged vs 09-2026 11-2026: 0.1%● unchanged vs 10-2026
Credit of up to €10,000 on 30-day terms is acceptable
Liquidity is ample, with a current ratio of 1.74 (1.08 in 2024), above the usual 1.5. Short-term debt is 40.6% and cash 15.1% of total assets. However, 70.2% of the assets are financed with debt and provisions.
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro). It does better than 26% of them on solvency, 18% on liquidity and 9% on profitability.

The bankruptcy probability was computed on 03-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Five signals.
lowers riskraises risk
lowers risk · Sector: Human health activities (NACE 86)
KBO
raises risk · Loss of €50,905 (financial year 2025)
NBB · annual accounts
lowers risk · Size: total assets €395,107
Companies of this size fail less often. How much that weighs depends on the rest of the company's profile.
NBB · annual accounts
lowers risk · Figures for financial year 2025 (filed on 26-08-2026)
NBB · annual accounts
raises risk · 2025 accounts filed 23 days late
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 23-08-2026, 23 days later. Nearly half (47%) of Belgian companies file late; of those that file 1 to 90 days late, 2.0% are now bankrupt, dissolved or in another special legal status, against 1.66% of all filers. A delay like this does not count in the score.
NBB · 10 filings
Deviation from the deadline
2025
23 days late
2024
on the day
2023
on the day
2022
10 days late
2021
on the day
2020
44 days late
2019
on the day
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 7 accounts on average 11 days after the deadline. In the sector (NACE 86), the median for financial year 2024 was 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (1)
neutral · No strike-offs in the KBO publications
That holds for every publication since 2021.
KBO publications

Key points

  • Caution: From profit to loss in 2025after a profit of €174,175 in 2024 -€50,905 View
  • Caution: Lower net result than 95% of companies in human healthsector median €110,424 · 2,999 companies -€50,905 View

Recent changes

  1. · Gazette deed Reappointment: ABBOUD Marwan (director)
  2. · Gazette deed Incorporation
All 18 events

Comparable companies

These companies have the same main activity as DOCTEUR ABBOUD: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €357,000 and €418,000, founded between 1999 and 2005.

CompanyTotal assetsGross margin
DOCTEUR ABBOUD Vorst€395,107€106,346
NUTATION Sint-Lambrechts-Woluwe€417,619€102,373
DOKTER G. GEUENS Nazareth-De Pinte€412,070€111,507
DOKTER J. ROOS Turnhout€384,849€102,894
DR. S. WYNANTS Hove€357,170€103,366
DR. H. VANDEN NEST, DERMATOLOOG Liedekerke€381,054€108,277
DOKTER F. BAUWENS Grimbergen€392,985€117,321
Full comparison

Key facts about DOCTEUR ABBOUD

What is the company number of DOCTEUR ABBOUD?
The company number of DOCTEUR ABBOUD is 0479.007.180. The VAT number is the same number with BE in front: BE 0479.007.180.
Where is DOCTEUR ABBOUD based?
The registered office is at Penelopelaan 23, 1190 Vorst.Company details
What does DOCTEUR ABBOUD do?
According to the KBO register, the main activity is specialist medical practice (NACE 86220).
What is the legal form of DOCTEUR ABBOUD?
The legal form of DOCTEUR ABBOUD is Private limited company (BV).
When was DOCTEUR ABBOUD founded?
DOCTEUR ABBOUD was founded on 13-12-2002.
Is DOCTEUR ABBOUD still active?
Yes, DOCTEUR ABBOUD is an active enterprise in the KBO register.
How many employees does DOCTEUR ABBOUD have?
DOCTEUR ABBOUD had an average of 0.2 full-time equivalents in financial year 2021, according to the filed annual accounts.Financials
Which joint committee does DOCTEUR ABBOUD fall under?
In its 30-06-2024 annual accounts, DOCTEUR ABBOUD states joint committee 336 (Paritair Comité voor de vrije beroepen).
What is the turnover of DOCTEUR ABBOUD?
The turnover in financial year 2025 is ≈ €200,000. This figure is estimated from the gross margin of €106,346 and 42 comparable companies (NACE 86220). It probably lies between €170,000 and €260,000.
Is DOCTEUR ABBOUD profitable?
In financial year 2025, DOCTEUR ABBOUD made a loss of €50,905.
Where can I find the annual accounts of DOCTEUR ABBOUD?
DOCTEUR ABBOUD filed 22 annual accounts with the National Bank of Belgium, the latest for financial year 2025.

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.